Consensus of German transplant centers on hematopoietic stem cell transplantation in Fanconi anemia

M. M. Chao, W. Ebell, P. Bader, R. Beier, B. Burkhardt, T. Feuchtinger, R. Handgretinger, H. Hanenberg, U. Koehl, C. Kratz, B. Kremens, P. Lang, R. Meisel, I. Mueller, C. Roessig, M. Sauer, P. G. Schlegel, A. Schulz, B. Strahm, F. TholK. W. Sykora

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Allogeneic hematopoietic stem cell transplantation (HSCT) is currently the only curative therapy for the severe hematopoietic complications associated with Fanconi anemia (FA). In Germany, it is estimated that 10-15 transplants are performed annually for FA. However, because FA is a DNA repair disorder, standard conditioning regimens confer a high risk of excessive regimen-related toxicities and mortality, and reduced intensity regimens are linked with graft failure in some FA patients. Moreover, development of graft-versus-host disease is a major contributing factor for secondary solid tumors. The relative rarity of the disorder limits HSCT experience at any single center. Consensus meetings were convened to develop a national approach for HSCT in FA. This manuscript outlines current experience and knowledge about HSCT in FA and, based on this analysis, general recommendations reached at these meetings.

Original languageEnglish (US)
Pages (from-to)157-165
Number of pages9
JournalKlinische Padiatrie
Volume227
Issue number3
DOIs
StatePublished - May 22 2015

Fingerprint

Fanconi Anemia
Hematopoietic Stem Cell Transplantation
Transplants
Graft vs Host Disease
DNA Repair
Germany
Mortality
Neoplasms

Keywords

  • consensus
  • fanconi anemia
  • recommendations
  • stem cell transplantation

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Chao, M. M., Ebell, W., Bader, P., Beier, R., Burkhardt, B., Feuchtinger, T., ... Sykora, K. W. (2015). Consensus of German transplant centers on hematopoietic stem cell transplantation in Fanconi anemia. Klinische Padiatrie, 227(3), 157-165. https://doi.org/10.1055/s-0035-1548841

Consensus of German transplant centers on hematopoietic stem cell transplantation in Fanconi anemia. / Chao, M. M.; Ebell, W.; Bader, P.; Beier, R.; Burkhardt, B.; Feuchtinger, T.; Handgretinger, R.; Hanenberg, H.; Koehl, U.; Kratz, C.; Kremens, B.; Lang, P.; Meisel, R.; Mueller, I.; Roessig, C.; Sauer, M.; Schlegel, P. G.; Schulz, A.; Strahm, B.; Thol, F.; Sykora, K. W.

In: Klinische Padiatrie, Vol. 227, No. 3, 22.05.2015, p. 157-165.

Research output: Contribution to journalArticle

Chao, MM, Ebell, W, Bader, P, Beier, R, Burkhardt, B, Feuchtinger, T, Handgretinger, R, Hanenberg, H, Koehl, U, Kratz, C, Kremens, B, Lang, P, Meisel, R, Mueller, I, Roessig, C, Sauer, M, Schlegel, PG, Schulz, A, Strahm, B, Thol, F & Sykora, KW 2015, 'Consensus of German transplant centers on hematopoietic stem cell transplantation in Fanconi anemia', Klinische Padiatrie, vol. 227, no. 3, pp. 157-165. https://doi.org/10.1055/s-0035-1548841
Chao, M. M. ; Ebell, W. ; Bader, P. ; Beier, R. ; Burkhardt, B. ; Feuchtinger, T. ; Handgretinger, R. ; Hanenberg, H. ; Koehl, U. ; Kratz, C. ; Kremens, B. ; Lang, P. ; Meisel, R. ; Mueller, I. ; Roessig, C. ; Sauer, M. ; Schlegel, P. G. ; Schulz, A. ; Strahm, B. ; Thol, F. ; Sykora, K. W. / Consensus of German transplant centers on hematopoietic stem cell transplantation in Fanconi anemia. In: Klinische Padiatrie. 2015 ; Vol. 227, No. 3. pp. 157-165.
@article{a1b55c49856744d8b514fbe3738dc87b,
title = "Consensus of German transplant centers on hematopoietic stem cell transplantation in Fanconi anemia",
abstract = "Allogeneic hematopoietic stem cell transplantation (HSCT) is currently the only curative therapy for the severe hematopoietic complications associated with Fanconi anemia (FA). In Germany, it is estimated that 10-15 transplants are performed annually for FA. However, because FA is a DNA repair disorder, standard conditioning regimens confer a high risk of excessive regimen-related toxicities and mortality, and reduced intensity regimens are linked with graft failure in some FA patients. Moreover, development of graft-versus-host disease is a major contributing factor for secondary solid tumors. The relative rarity of the disorder limits HSCT experience at any single center. Consensus meetings were convened to develop a national approach for HSCT in FA. This manuscript outlines current experience and knowledge about HSCT in FA and, based on this analysis, general recommendations reached at these meetings.",
keywords = "consensus, fanconi anemia, recommendations, stem cell transplantation",
author = "Chao, {M. M.} and W. Ebell and P. Bader and R. Beier and B. Burkhardt and T. Feuchtinger and R. Handgretinger and H. Hanenberg and U. Koehl and C. Kratz and B. Kremens and P. Lang and R. Meisel and I. Mueller and C. Roessig and M. Sauer and Schlegel, {P. G.} and A. Schulz and B. Strahm and F. Thol and Sykora, {K. W.}",
year = "2015",
month = "5",
day = "22",
doi = "10.1055/s-0035-1548841",
language = "English (US)",
volume = "227",
pages = "157--165",
journal = "Klinische Padiatrie",
issn = "0300-8630",
publisher = "Georg Thieme Verlag",
number = "3",

}

TY - JOUR

T1 - Consensus of German transplant centers on hematopoietic stem cell transplantation in Fanconi anemia

AU - Chao, M. M.

AU - Ebell, W.

AU - Bader, P.

AU - Beier, R.

AU - Burkhardt, B.

AU - Feuchtinger, T.

AU - Handgretinger, R.

AU - Hanenberg, H.

AU - Koehl, U.

AU - Kratz, C.

AU - Kremens, B.

AU - Lang, P.

AU - Meisel, R.

AU - Mueller, I.

AU - Roessig, C.

AU - Sauer, M.

AU - Schlegel, P. G.

AU - Schulz, A.

AU - Strahm, B.

AU - Thol, F.

AU - Sykora, K. W.

PY - 2015/5/22

Y1 - 2015/5/22

N2 - Allogeneic hematopoietic stem cell transplantation (HSCT) is currently the only curative therapy for the severe hematopoietic complications associated with Fanconi anemia (FA). In Germany, it is estimated that 10-15 transplants are performed annually for FA. However, because FA is a DNA repair disorder, standard conditioning regimens confer a high risk of excessive regimen-related toxicities and mortality, and reduced intensity regimens are linked with graft failure in some FA patients. Moreover, development of graft-versus-host disease is a major contributing factor for secondary solid tumors. The relative rarity of the disorder limits HSCT experience at any single center. Consensus meetings were convened to develop a national approach for HSCT in FA. This manuscript outlines current experience and knowledge about HSCT in FA and, based on this analysis, general recommendations reached at these meetings.

AB - Allogeneic hematopoietic stem cell transplantation (HSCT) is currently the only curative therapy for the severe hematopoietic complications associated with Fanconi anemia (FA). In Germany, it is estimated that 10-15 transplants are performed annually for FA. However, because FA is a DNA repair disorder, standard conditioning regimens confer a high risk of excessive regimen-related toxicities and mortality, and reduced intensity regimens are linked with graft failure in some FA patients. Moreover, development of graft-versus-host disease is a major contributing factor for secondary solid tumors. The relative rarity of the disorder limits HSCT experience at any single center. Consensus meetings were convened to develop a national approach for HSCT in FA. This manuscript outlines current experience and knowledge about HSCT in FA and, based on this analysis, general recommendations reached at these meetings.

KW - consensus

KW - fanconi anemia

KW - recommendations

KW - stem cell transplantation

UR - http://www.scopus.com/inward/record.url?scp=84929577617&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929577617&partnerID=8YFLogxK

U2 - 10.1055/s-0035-1548841

DO - 10.1055/s-0035-1548841

M3 - Article

C2 - 25985449

AN - SCOPUS:84929577617

VL - 227

SP - 157

EP - 165

JO - Klinische Padiatrie

JF - Klinische Padiatrie

SN - 0300-8630

IS - 3

ER -